Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tor-Morten Kvam"'
Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample
Autor:
Tor-Morten Kvam, Malin V. Uthaug, Kristoffer A. A. Andersen, Birk Berggrav Refsum, Paula Aarseth Tunstad, Lowan Han Stewart, Henrik Børsting Jacobsen, Cato Grønnerød
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
ObjectiveIn recent years, there has been a renewed interest in investigating the use of classic psychedelics such as psilocybin and lysergic acid diethylamide (LSD) in the treatment of mental disorders and substance use disorders. However, knowledge
Externí odkaz:
https://doaj.org/article/cccd74f2e60441d7a076458b70d3a399
Autor:
Tor-Morten Kvam, Ivar W. Goksøyr, Lowan H. Stewart, Dimitris Repantis, Jan Ivar Røssberg, Ole A. Andreassen
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
BackgroundMajor depressive disorder (MDD) is a world-leading cause of disability. The available treatments are not effective in all patients, and there is a significant need for more effective treatment options. Here we present the protocol for an in
Externí odkaz:
https://doaj.org/article/ce741554022e46fcba085c22412e7756
Publikováno v:
UnpayWall
ORCID
Microsoft Academic Graph
ORCID
Microsoft Academic Graph
BackgroundPsilocybin is emerging as a promising therapeutic agent for a wide range of psychiatric conditions, and clinical trials on psilocybin-assisted treatment are forthcoming in Scandinavian countries. However, little is known about attitudes tow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56c40874daf437851bd3ed3cbd74b776
https://akjournals.com/downloadpdf/journals/2054/5/1/article-p33.pdf
https://akjournals.com/downloadpdf/journals/2054/5/1/article-p33.pdf
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 141
Current treatment for serious depression is unsatisfactory, and many patients fail to achieve the desired effect. Ketamine represents a new treatment option, and randomised trials show a rapid effect of intravenous ketamine. Although knowledge about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22223d69ba8fe35170c527ffa1db0a26
https://pubmed.ncbi.nlm.nih.gov/34758606
https://pubmed.ncbi.nlm.nih.gov/34758606
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31f63618fa0f9e4fc0001c056c3f3989
https://doi.org/10.4045/tidsskr.21.0760
https://doi.org/10.4045/tidsskr.21.0760
Publikováno v:
Tidsskrift for Den norske legeforening.
Current treatment for serious depression is unsatisfactory, and many patients fail to achieve the desired effect. Ketamine represents a new treatment option, and randomised trials show a rapid effect of intravenous ketamine. Although knowledge about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d61a2b40b5a4f32c2adfa8f3cb14a247
https://doi.org/10.4045/tidsskr.21.0480
https://doi.org/10.4045/tidsskr.21.0480
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 138(18)
Det er økt interesse for psykedeliske stoffer til bruk i behandling av psykiske lidelser. Stoffene regnes som trygge når de gis innenfor en klinisk ramme. Eldre studier fra før 1970 har metodologiske svakheter, men i de senere år har det kommet l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44f09b9e6c593b377e24995664641837
https://pubmed.ncbi.nlm.nih.gov/30421744
https://pubmed.ncbi.nlm.nih.gov/30421744
Publikováno v:
Tidsskrift for Den norske legeforening.
Bakgrunn Det er okt interesse for psykedeliske stoffer til bruk i behandling av psykiske lidelser. Stoffene regnes som trygge nar de gis innenfor en klinisk ramme. Eldre studier fra for 1970 har metodologiske svakheter, men i de senere ar har det kom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a7f11a63e3d6cfe527ac008ac4656f0
https://doi.org/10.4045/tidsskr.17.1110
https://doi.org/10.4045/tidsskr.17.1110
Autor:
Frank Skorpen, Ola Dale, Tor-Morten Kvam, Trude T. Rakvåg, Pål Klepstad, Cecilie Baar, Hans E. Krokan, Stein Kaasa
Publikováno v:
Pain. 116:73-78
Catechol-O-methyltransferase (COMT) inactivates dopamine, epinephrine and norepinephrine in the nervous system. A common functional polymorphism (Val158Met) leads to a three- to-four-fold variation in the COMT enzyme activity, the Met form displaying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3eba56d9019fb2c8ade897c991a14fa
https://doi.org/10.1016/j.pain.2005.03.032
https://doi.org/10.1016/j.pain.2005.03.032
Publikováno v:
Journal of molecular medicine (Berlin, Germany). 82(4)
Evidence exists that mu analgesics such as morphine, methadone and fentanyl may act through distinct mu opioid receptor mechanisms. It has been proposed that the functional diversity of mu opioid receptors may be related to alternative splicing of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35dec3cdbe44aecb8b2a3c123eeb7d1b
https://pubmed.ncbi.nlm.nih.gov/14991152
https://pubmed.ncbi.nlm.nih.gov/14991152